108946001: Paricalcitol (substance)

SNOMED CT Concept\Substance\...

\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Vitamin\Fat-soluble vitamin\Vitamin D and/or vitamin D derivative\Paricalcitol

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\Organic compound\Organic cyclic compound\Polycyclic compound (substance)\Steroid (substance)\Vitamin D and/or vitamin D derivative\Paricalcitol

\Biological substance (substance)\Nutrients\Vitamin\Fat-soluble vitamin\Vitamin D and/or vitamin D derivative\Paricalcitol

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

173480015 Paricalcitol en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

606480014 Paricalcitol (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

3256461000005112 paricalcitol da Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) Danish module (core metadata concept)

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Paricalcitol	Is a	Product containing vitamin D and/or vitamin D derivative (product)	false	Inferred relationship	Some
Paricalcitol	Is a	Vitamin D and/or vitamin D derivative	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Product containing paricalcitol (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Paricalcitol	Inferred relationship	Some	1
alkohol 20 % vol/vol + paricalcitol 5 µg + propylenglycol 30 % vol/vol opløsning	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Paricalcitol	Inferred relationship	Some
alkohol + paricalcitol + propylenglycol	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Paricalcitol	Inferred relationship	Some
Product containing precisely paricalcitol 1 microgram/1 each conventional release oral capsule (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Paricalcitol	Inferred relationship	Some
Product containing precisely paricalcitol 2 microgram/1 each conventional release oral capsule (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Paricalcitol	Inferred relationship	Some
Product containing precisely paricalcitol 4 microgram/1 each conventional release oral capsule (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Paricalcitol	Inferred relationship	Some
paricalcitol 5 µg/ml injektionsvæske, opløsning, ampul a 1 ml	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Paricalcitol	Inferred relationship	Some
paricalcitol 5 µg/ml injektionsvæske, opløsning, ampul a 2 ml	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Paricalcitol	Inferred relationship	Some
Product containing paricalcitol in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Paricalcitol	Inferred relationship	Some	1
Product containing paricalcitol in parenteral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Paricalcitol	Inferred relationship	Some	1
Product containing precisely paricalcitol 4 microgram/1 each conventional release oral capsule (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Paricalcitol	Inferred relationship	Some	1
Product containing precisely paricalcitol 4 microgram/1 each conventional release oral capsule (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Paricalcitol	Inferred relationship	Some	1
Product containing precisely paricalcitol 1 microgram/1 each conventional release oral capsule (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Paricalcitol	Inferred relationship	Some	1
Product containing precisely paricalcitol 1 microgram/1 each conventional release oral capsule (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Paricalcitol	Inferred relationship	Some	1
Product containing precisely paricalcitol 2 microgram/1 each conventional release oral capsule (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Paricalcitol	Inferred relationship	Some	1
Product containing precisely paricalcitol 2 microgram/1 each conventional release oral capsule (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Paricalcitol	Inferred relationship	Some	1
Product containing precisely paricalcitol 2 microgram/1 each conventional release oral capsule (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Paricalcitol	Inferred relationship	Some	1
Product containing precisely paricalcitol 1 microgram/1 each conventional release oral capsule (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Paricalcitol	Inferred relationship	Some	1
Product containing precisely paricalcitol 4 microgram/1 each conventional release oral capsule (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Paricalcitol	Inferred relationship	Some	1
Product containing precisely paricalcitol 5 microgram/1 milliliter conventional release solution for injection ampule	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Paricalcitol	Inferred relationship	Some	1
Product containing precisely paricalcitol 5 microgram/1 milliliter conventional release solution for injection ampule	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Paricalcitol	Inferred relationship	Some	1
Product containing precisely paricalcitol 10 microgram/2 milliliter conventional release solution for injection ampule	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Paricalcitol	Inferred relationship	Some	1
Product containing precisely paricalcitol 10 microgram/2 milliliter conventional release solution for injection ampule	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Paricalcitol	Inferred relationship	Some	1
Product containing only paricalcitol (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Paricalcitol	Inferred relationship	Some	1
Paricalcitol only product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Paricalcitol	Inferred relationship	Some	1
Product containing only paricalcitol in parenteral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Paricalcitol	Inferred relationship	Some	1
Product containing precisely paricalcitol 5 microgram/1 milliliter conventional release solution for injection (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Paricalcitol	Inferred relationship	Some	1
Product containing precisely paricalcitol 5 microgram/1 milliliter conventional release solution for injection (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Paricalcitol	Inferred relationship	Some	1

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
173480015	Paricalcitol	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
606480014	Paricalcitol (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
3256461000005112	paricalcitol	da	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	Danish module (core metadata concept)